Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica

Page 1 of about 3 results

ea0063oc11.1 | Diabetes 2 | ECE2019

Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study

Tatulashvili Sopio , Gusto Gaelle , Balkau Beverley , Cosson Emmanuel , Bonnet Fabrice , Bihan Helene , Fagherazzi Guy

Background: Early screening and the treatment of glucose metabolism disorders could lower the risk of further complications. For this purpose it is important to identify the risk factors of type 2 diabetes mellitus (T2DM). The aim of this study was to determine the association between various hormonal factors and the risk of incident type 2 diabetes in the large prospective female E3N cohort study.Material and methods: The study included 83,799 French wo...
0 shares

ea0063gp214 | Gestational and Type 1 Diabetes | ECE2019

Association between sleep disturbances and fear of hypoglycemia in adults with type 1 diabetes, data from VARDIA Study

Suteau Valentine , Saulnier Pierre-Jean , Wargny Matthieu , Gand Elise , Chaillous Lucy , Dubois Severine , Allix Ingrid , Bonnet Fabrice , Leguerrier Anne-Marie , Fradet Gerard , Crespin Isabelle Delcourt , Kerlan Veronique , Gouet Didier , Perlemoine Caroline , Ducluzeau Pierre-Henri , Pichelin Matthieu , Gonder-Frederic Linda , Ragot Stephanie , Hadjhadj Samy , Cariou Bertrand , Briet Claire

Aims: To assess the relationship between sleep quality and fear of hypoglycemia, glycemic variability and other diabetes-related outcomes in type 1 diabetes.Methods: Our data were provided by the VARDIA Study, a multicentric observational cross-sectional study conducted between June and December 2015. Sleep characteristics were assessed by Pittsburgh Sleep Quality Index (PQ1I). Fear of hypoglycemia was measured with the Hypoglycemia Fear Survey version I...
0 shares

ea0037gp.30.01 | Endocrine tumours and neoplasia – General | ECE2015

Temozolomide treatment for pituitary aggressive tumours and pituitary carcinomas: initial results and long-term follow-up of a cohort of 32 cases

Lasolle Helene , Castinetti Frederic , Cortet Christine , Cloix Lucie , Batisse-Lignier Marie , Bonnet Fabrice , Bourcigaux Nathalie , Chabre Olivier , Chanson Philippe , Delemer Brigitte , Lebrun-Frenay Christine , Garcia Cyril , Reznik Yves , Schillo Franck , Taillandier Luc , Maiter Dominique , Sadoul Jean-Louis , Caron Philipe , Raverot Gerald

Context: Successful used of temozolomide (TMZ) treatment has been described in 40–50% of aggressive pituitary tumour (PT) or rare pituitary carcinoma. These results are based on 50 case-reports and small series, data on long-term follow-up being rare.Objectives: To describe initial results and long-term follow-up of a large French cohort of patients presenting PT treated with temozolomide.Design: Members of the French Society ...
0 shares

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more